gemtuzumab ozogamicin
Ligand Summary
Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.
ChEMBL: CHEMBL1201506
DrugCentral: 4980
LyCHI: gemtuzumab ozogamicin
Target Activities
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
ANTIBODY BINDING | ||||||